Medtronic Achieves Three Milestones for MiniMed 780G System in US
3 Articles
3 Articles
Medtronic achieves three milestones for MiniMed 780G system in US
Medtronic has reported three milestones in the US, expanding access to its MiniMed 780G insulin delivery system for individuals with type 1 and insulin-requiring type 2 diabetes.The post Medtronic achieves three milestones for MiniMed 780G system in US appeared first on Medical Device Network.
Medtronic earns Medicare, FDA wins for MiniMed 780G, Instinct
A person wears the MiniMed 780G pump on the hip with the Instinct sensor on the arm. [Image courtesy of Medtronic]Medtronic (NYSE:MDT) today announced three U.S. milestones expanding access to its MiniMed 780G automated insulin delivery system. The company announced Medicare access for MiniMed 780G paired with the Instinct sensor made by Abbott, FDA clearance for the pairing for insulin-requiring type 2 diabetes and FDA clearance for the system’…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium